WHO lists AstraZeneca-Oxford vaccine for emergency use
Two sites, including Serum Institute, to produce it despite global concerns over age and virus variants16-02-2021
16-02-2021
Coronavirus News LIVE Updates | UN approves AstraZeneca''s COVID-19 vaccine for emergency use
Coronavirus News LIVE: Today is the 328th day since India implemented a nationwide lockdown to help curb the novel coronavirus pandemic. So far, India has recorded 1,09,04,940 confirmed COVID-19 cases, including 1,55,642 deaths.16-02-2021
UN approves AstraZeneca's Covid-19 vaccine for emergency use
WHO has granted an emergency authorization to AstraZeneca's Covid vaccine, a move that should allow the UN agency's partners to ship millions of doses to countries worldwide16-02-2021
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate as per attached details.14-02-2021
Covishield vaccine being procured by govt at Rs 210 per dose: MoS Health
Minister of State for Health Ashwini Choubey was responding to a question on whether the government is aware that the Oxford-AstraZeneca vaccine is being sold to European Union nations at comparatively lower price that to India.13-02-2021
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith Certificate dated February 5, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.12-02-2021
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing a copy of newspaper advertisement published in Business Standard and Prajavani newspapers.12-02-2021
Vaccine against new Covid variants may take 6-9 months: AstraZeneca
Pharmaceutical company AstraZeneca said it could take between six to nine months to produce Covid-19 vaccines that are effective against new variants of the virus11-02-2021
Oxford-AstraZeneca Covid-19 vaccine recommended for all adults by WHO panel
The shot's effect in older people is expected to be the same as for younger recipients, said Alejandro Cravioto, chairman of the WHO panel, in a briefing10-02-2021
AstraZeneca Pharma India Q3 net profit declines 21% at Rs 21 crore
Drug firmAstraZeneca Pharma India on Monday reported a 21 per cent decline in net profit at Rs 21.05 crore for the quarter ended in December08-02-2021